Evidence map›Paper›PMID 28722304›Full record

ReviewAging cell2017

Nrf2 as a target for prevention of age-related and diabetic cataracts by against oxidative stress.

Xiu-Fen Liu, Ji-Long Hao, Tian Xie, Tayyab Hamid Malik, Cheng-Bo Lu, Cong Liu, Chang Shu, Cheng-Wei Lu, Dan-Dan Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Aging cell, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Butylphthalide inhibits ferroptosis and ameliorates cerebral Ischaemia-Reperfusion injury in rats by activating the Nrf2/HO-1 signalling pathway.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Xiu-Fen LiuDepartment of Ophthalmology, The First Hospital of Jilin University, Jilin, China.
Ji-Long HaoDepartment of Ophthalmology, The First Hospital of Jilin University, Jilin, China.
Tian XieDepartment of Neurosurgery, The People's Hospital of Jilin Province, Jilin, China.
Tayyab Hamid MalikDepartment of Gastroenterology, The First Hospital of Jilin University, Jilin, China.
Cheng-Bo LuDepartment of Cardiology, The First Hospital of Jiamusi University, Heilongjiang, China.
Cong LiuDepartment of Ophthalmology, The First Hospital of Jilin University, Jilin, China.
Chang ShuDepartment of Obstetrics and Gynecology, The First Hospital of Jilin University, Jilin, China.
Cheng-Wei LuDepartment of Ophthalmology, The First Hospital of Jilin University, Jilin, China.
Dan-Dan ZhouDepartment of Radiology, The First Hospital of Jilin University, Jilin, China.
Jilin University · CNPeople 's Hospital of Jilin Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cataract is one of the most important causes of blindness worldwide, with age-related cataract being the most common one. Agents preventing cataract formation are urgently required. Substantial evidences point out aggravated oxidative stress as a vital factor for cataract formation. Nuclear factor (erythroid-derived 2)-like 2 (Nrf2)/Kelch-like erythroid-cell-derived protein with CNC homology (ECH)-associated protein 1 (Keap1) system is considered as one of the main cellular defense mechanisms against oxidative stresses. This review discusses the role of Nrf2 pathway in the prevention of cataracts and highlights that Nrf2 suppressors may augment oxidative stress of the lens, and Nrf2 inducers may decrease the oxidative stress and prevent the cataract formation. Thus, Nrf2 may serve as a promising therapeutic target for cataract treatment.

Indexed as

AgingAntioxidantsBenzofuransBlindnessCataractFlavonesFlavonoidsGene Expression Regulation, DevelopmentalHumansKelch-Like ECH-Associated Protein 1Lens, CrystallineNF-E2-Related Factor 2Oxidative StressQuercetinSignal TransductionTranscription, Genetic3-n-butylphthalideAntioxidantsBenzofuransFlavonesFlavonoidshyperosideKEAP1 protein, humanKelch-Like ECH-Associated Protein 1morinNFE2L2 protein, humanNF-E2-Related Factor 2Quercetinantioxidant response elementcataractsKeap1lensesNrf2oxidative stress

Identifiers

PMID28722304
PMCPMC5595676
OpenAlexW2737474548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.